ロード中...
Androgen receptor splice variants mediate enzalutamide resistance in castration-resistant prostate cancer cell lines
Persistent androgen receptor (AR) transcriptional activity underlies resistance to AR-targeted therapy and progression to lethal castration resistant prostate cancer (CRPC). Recent success in re-targeting persistent AR activity with next-generation androgen/AR axis inhibitors such as enzalutamide (M...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3549016/ https://ncbi.nlm.nih.gov/pubmed/23117885 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-12-3630 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|